December 12, 2024 17:32 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked

The news of rising COVID cases coming out of China is concerning: SII CEO Adar Poonawalla

Dec 21, 2022, at 08:42 pm

Mumbai: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday expressed concern over the rising COVID-19 cases in China and said the issue is 'concerning'.

COVID-19: Covishield shot reduced from Rs.600 to Rs.225, announces Adar Poonawalla

Apr 09, 2022, at 09:20 pm

Mumbai:  Serum Institute of India CEO Adar Poonawalla on Saturday announced the price of Covishield shot for private hospitals has been reduced from Rs. 600 to Rs. 225.

Vaccine for children above 3 years in next 6 months: Adar Poonawalla

Dec 15, 2021, at 01:16 am

New Delhi/UNI: Amid concern over the spread of the Omicron variant of Covid-19 virus and vulnerability of children, Adar Poonawalla, Chief Executive Officer of the Serum Institute of India, on Tuesday said alongwith two other companies, SII has reached the trial phase of developing a vaccine for the children aged above three and it should be ready within the next 6 months.

Vaccine hesitancy is now the greatest threat in overcoming pandemic: Adar Poonawalla

Nov 18, 2021, at 06:04 am

New Delhi/IBNS:  Serum Institute of India chief Adar Poonawalla, whose pharma company manufactured COVID-19 vaccine Covishield, on Wednesday said the hesitancy to get inoculated is the "greatest threat" in overcoming the pandemic.

'A new milestone has been reached', says Serum Institute as it starts production of first batch of Covavax

Jun 26, 2021, at 06:18 am

Pune/IBNS: The Serum institute of India, which started manufacturing the first batch of Novavax's Covid-19 vaccine in India under the name Covavax, said "a new milestone has been reached".

Serum Institute gets preliminary approval to make Sputnik V vaccine

Jun 05, 2021, at 04:57 am

Pune/IBNS: Adar Poonawalla's Serum Institute of India (SII) has got preliminary permission from the country's drugs regulator to make the Russian COVID-19 vaccine Sputnik V, media reports said.

Serum Institute to sell Covishield to states at Rs. 400, private hospitals at Rs. 600

Apr 21, 2021, at 07:17 pm

Pune/IBNS: The Serum Institute of India (SII) has decided to sell one dose of its Covid-19 vaccine, named Covishield, to state governments at Rs. 400 and private hospitals at Rs. 600, as India will enter into a liberalised vaccination drive from May 1.

'Please be patient': Adar Poonawalla urges nations waiting for Covishield vaccines

Feb 21, 2021, at 06:36 pm

Pune/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Sunday requested countries and governments to "be patient" amid the wait for 'Covishield' supplies, the coronavirus vaccine his pharmaceutical company has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.

Covishield ready to roll out in coming weeks: SII CEO Adar Poonawalla

Jan 03, 2021, at 09:11 pm

New Delhi/UNI: Hours after the Drugs Controller General of India (DGCI) approved Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' for restricted emergency use, Serum Institute of India (SII) CEO Adar Poonawalla announced that the vaccine is ready to roll out in the coming weeks.

Serum Institute applies for emergency approval of Covishield

Dec 07, 2020, at 05:27 pm

New Delhi/IBNS: The Serum Institute of India (SII) has applied for an emergency approval from the Indian government of its vaccine against Covid-19, named Covishield.

India reports over 48,000 Covid-19 cases in 24 hours, active cases fall below 6 lakh

Oct 30, 2020, at 05:00 pm

New Delhi/IBNS: India, the second worst Covid-19-affected country in the world, reported over 48,000 new cases in the last 24 hours, taking the overall tally of infections to 80,88,851.

Covid-19 vaccine could be ready by December: Serum Institute's Adar Poonawalla

Oct 29, 2020, at 04:38 pm

New Delhi/Pune/IBNS: Giving a hope to 1.3 billion people of India, vaccine manufacturer Serum Institute of India (SII)'s chief Adar Poonawalla has said the Oxford University's Covid-19 vaccine can be made available in the country by December 2020.

Will the government of India have 80,000 crores available for COVID-19 vaccines: Serum Institute of India CEO Adar Poonawalla asks

Sep 26, 2020, at 10:54 pm

New Delhi: Serum Institute of India CEO Adar Poonawalla on Saturday asked whether the Indian government will have Rs. 80,000 crores over the next one year to buy and distribute the COVID-19 vaccine to everyone in India.

Will take 4-5 years until everyone gets COVID-19 vaccine, says Serum Institute of India CEO Adar Poonawalla 

Sep 14, 2020, at 11:40 pm

Pune: Adar Poonawalla, chief executive of the Serum Institute of India, has said it will take four to five years until everyone gets the COVID-19 vaccine on this planet.